Genetic medicines: treatment strategies for hereditary disorders
Authors:
- Ronald G. CrystalRCRonald G. Crystal
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 7 (4) , 261-276
Abstract
The treatment of the more than 1,800 known monogenic hereditary disorders will depend on the development of 'genetic medicines' - therapies that use the transfer of DNA and/or RNA to modify gene expression to correct or compensate for an abnormal phenotype. Strategies include the use of somatic stem cells, gene transfer, RNA modification and, in the future, embryonic stem cells. Despite the efficacy of these technologies in treating experimental models of hereditary disorders, applying them successfully in the clinic is a great challenge, which will only be overcome by expending considerable intellectual and economic resources, and by solving societal concerns about modifications of the human genetic repertoire.Keywords
This publication has 155 references indexed in Scilit:
- High Levels of Persistent Expression of α1-Antitrypsin Mediated by the Nonhuman Primate Serotype rh.10 Adeno-associated Virus Despite Preexisting Immunity to Common Human Adeno-associated VirusesMolecular Therapy, 2006
- Efficient Hepatic Delivery and Expression from a Recombinant Adeno-associated Virus 8 Pseudotyped α1-Antitrypsin VectorMolecular Therapy, 2005
- The molecular repertoire of the 'almighty' stem cellNature Reviews Molecular Cell Biology, 2005
- Characterization and culture of human embryonic stem cellsNature Biotechnology, 2005
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- Approaches for the sequence-specific knockdown of mRNANature Biotechnology, 2003
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Regulatory Issues for Clinical Gene Therapy TrialsHuman Gene Therapy, 2002
- Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC)Human Gene Therapy, 1999